Product Number |
ARP32513_P050 |
Product Page |
www.avivasysbio.com/hey1-antibody-c-terminal-region-arp32513-p050.html |
Name |
Hey1 Antibody - C-terminal region (ARP32513_P050) |
Protein Size (# AA) |
292 amino acids |
Molecular Weight |
32 kDa |
NCBI Gene Id |
155437 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
0.5 mg/ml |
Gene Full Name |
Hairy/enhancer-of-split related with YRPW motif 1 |
Alias Symbols |
Herp2 |
Peptide Sequence |
Synthetic peptide located within the following region: WGSAFGHHPHIAHPLLLPQNGHGNAGTTASPTEPHHQGRLASAHPEAPAL |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Description of Target |
Hey1 is a primary target of Notch that plays a central role in the development of the aorta. |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-Hey1 (ARP32513_P050) antibody |
Blocking Peptide |
For anti-Hey1 (ARP32513_P050) antibody is Catalog # AAP32513 (Previous Catalog # AAPP03516) |
Uniprot ID |
D3ZNI5 |
Protein Name |
Protein Hey1 Ensembl ENSRNOP00000015537 |
Protein Accession # |
NP_001178774 |
Purification |
Affinity Purified |
Nucleotide Accession # |
NM_001191845 |
Tested Species Reactivity |
Rat |
Gene Symbol |
Hey1 |
Predicted Species Reactivity |
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Cow: 79%; Dog: 79%; Guinea Pig: 100%; Horse: 93%; Human: 100%; Mouse: 93%; Rat: 100% |
Image 1 | Rat Muscle
| WB Suggested Anti-Hey1 Antibody Titration: 1.0 ug/ml Positive Control: Rat Muscle |
| Image 2 |
| Surface Plasmon Resonance Kinetic Characterization of Polyclonal Antibody Affinity. Purified polyclonal antibodies were immobilized on a Protein A/G coated Carterra LSA sensor chip (PAGH200M) at concentrations of 5, and 50 ug/mL in duplicate. Antibodies on the surface were exposed to interaction with peptides sequentially via microfluidic controlled flow at 333nM peptide concentration for kinetic characterization of the binders for affinity and specificity, followed by curve fitting using the Kinetics software. Kd determinations for both concentrations were averaged and results and standard deviation are shown.
|
|
|